В проучване V при пациенти с ранен ревматоиден артрит, нелекувани преди с метотрексат, ка
In Studies I-IV, Trudexa-treated patients achieved statistically significant ACR 20 and 50 responses compared to placebo as early as one to two weeks after initiation of treatment.